Hisato Kawakami

56PUBLICATIONS
210CO-AUTHORS
Predictive and prognostic markersMolecular targetsOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Cellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Sep 21, 2026
Early-onset chemotherapy-induced neutropenia and ascites control in patients with severe peritoneal metastasis of gastric cancer: a post hoc analysis of the JCOG1108/WJOG7312G trial.

|Sep 19, 2026
Tumor-associated calcium signal transducer 2 expression as a promising therapeutic target in esophageal squamous cell carcinoma: a combined the Cancer Genome Atlas and an institutional cohort.

|Sep 05, 2026
PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.

|Jul 07, 2026
Intratumoral heterogeneity of intermediate CLDN18.2 expression in gastric cancer.

|Apr 23, 2026
Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling Pathway.

|Nov 04, 2025
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer.

Yusuke Kinugasa, Kay Uehara, Kensei Yamaguchi

Pageof 10

Frequent Collaborators

8 joint publications

Takayuki Yoshino

8 joint publications

Hiroki Hara

7 joint publications

Hidetoshi Hayashi

6 joint publications

Hiroya Taniguchi